[Federal Register Volume 60, Number 163 (Wednesday, August 23, 1995)]
[Notices]
[Page 43807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20908]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Meetings

    Pursuant to Sec. 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of advisory 
committee meetings of the National Cancer Institute.
    These meetings will be open to the public, as indicated below, to 
discuss administrative details or other issues relating to committee 
activities, for the review of concepts being considered for funding, 
and for public testimony on the latest technology available to the 
research community in the area of cancer research. Attendance by the 
public will be limited to space available.
    These meetings will be closed to the public as indicated below. The 
President's Cancer Panel will be closed in accordance with the 
provisions set forth in sec. 552b(c)(9)(B), Title 5, U.S.C. for the 
review of the expert testimony and formulation of recommendations. This 
review could disclose information the premature disclosure of which 
would be likely to significantly frustrate due consideration of the 
testimony presented and formulation of recommendations. The Board of 
Scientific Counselors will be closed in accordance with the provisions 
set forth in sec. 552b(c)(6), Title 5, U.S.C. for the review, 
discussion and evaluation of individual programs and projects, 
including consideration of personnel qualifications and performance, 
and the competence of individual investigators. These discussions could 
reveal confidential information concerning individuals associated with 
the programs and projects, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.
    Carole Frank, the Committee Management Officer, National Cancer 
Institute, Executive Plaza North, Room 630M, 6130 Executive Blvd., MSC 
7405, Bethesda, MD 20892-7405, (301-496-5708) will provide a summary of 
the meeting and the roster of committee members upon request. Other 
information pertaining to the meetings may be obtained from the contact 
person indicated below.
    Individuals who plant to attend and need special assistance, such 
as sign language interpretation or other reasonable accommodations, 
should notify the contact person listed for that particular meeting.

    Committee Name: President's Cancer Panel.
    Contact Person: Dr. Maureen O. Wilson, Executive Secretary, 
National Cancer Institute, NIH, Building 31, Room 4B43, 9000 
Rockville Pike, Bethesda, MD 20892, (301) 496-1148.
    Date of Meeting: September 15, 1995.
    Place of Meeting: University of Maryland Medical School, 
Teaching Facility, Auditorium 10, South Pine Street, Baltimore, MD 
21201.
    Open: September 15--8 am to 3 pm and 4 pm to 5 pm.
    Agenda: Testimony from experts on the latest technology 
available to the cancer research community. After closed 
deliberations, the Panel will report on the recommendations to be 
made on the future of cancer research, its successes, failures and 
needs for improvement.
    Closed: September 15--3 pm to 4 pm.
    Agenda: Review, discussion and evaluation of the testimony given 
in open session and formulation of recommendations.

    Committee Name: Board of Scientific Counselors, Division of 
Cancer Etiology.
    Contact Person: Dr. Jerry M. Rice, Executive Secretary, Building 
31, Room 11A03, 9000 Rockville Pike, Bethesda, MD 20892, 301-496-
6618.
    Dates of Meeting: October 5-6, 1995.
    Place of Meeting: Building 31, Conference Room 6, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: October 5--9 am to 12 pm.
    Agenda: Review progress of programs within the Division and 
review of concepts being considered for funding.
    Closed: October 5--1 pm to 5 pm. October 6--9 am to Adjournment.
    Agenda: Extramural/Intramural programmatic and personnel 
policies of a sensitive nature and consideration of personnel 
qualifications and performance, and the competence of individual 
investigators.

    (Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control.)

    Dated: August 17, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-20908 Filed 8-22-95; 8:45 am]
BILLING CODE 4140-01-M